Saniona (SANION) Completes Tox and CMC for SAN2465, Targets IND by Oct 2026

Saniona completed toxicology and CMC work for SAN2465 and expects to submit an IND to the FDA by the end of October 2026. A Phase 1 study in healthy volunteers is planned.Material DetailsContext by AI AnalystThis is an early clinical-stage milestone advancing a preclinical asset toward first-in-hum…